Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled...

por Fleishaker, Dona L, Garcia Meijide, Juan A, Petrov, Andriy, Kohen, Michael David, Wang, Xin, Menon, Sujatha, Stock, Thomas C, Mebus, Charles A, Goodrich, James M, Mayer, Howard B, Zeiher, Bernhardt G
Publicado 2012